Bristol-Myers Squibb

High Value Found in Small Changes

Blog

Small changes can add up to big savings and Bristol-Myers Squibb knows that very well. Since 2015, the company has identified hundreds of opportunities to reduce emissions and energy and water consumption, equating to more than $11 million in cost savings.

Driving Change for Diverse Patient Communities

Blog

Editor’s note: In recognition of Global Patient Week, held annually across Bristol-Myers Squibb to celebrate the company’s patient-focused culture, we’re sharing how our People and Business Resource Groups are driving change for diverse patient populations. 

When Priscilla Ko, a manager in the Bristol-Myers Squibb Foundation and member of the PAN Asian Network People and Business Resource Group, watched her father-in-law lose his battle with an aggressive form of bile-duct cancer at the age of 61, the personal suddenly turned professional.  

Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics

Press Release

PRINCETON, N.J. and CAMBRIDGE, Mass., December 10, 2018 /3BL Media/ - Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today announced that ReviveMed and Strand Therapeutics are the winners of Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral.

Going the Extra Mile for Patients

Blog

For Darcy Doege, R.N., B.S.N., of the Levine Cancer Institute, finding cancer early in patients means hitting the road.

Darcy is the Program Coordinator for the Lung B.A.S.E.S. 4 Life Program for the Charlotte-based cancer center, which launched the first mobile lung screening unit in the U.S. in 2017. This innovative idea was built to increase the early detection of lung cancer for underserved populations across North and South Carolina, thanks to a grant from the Bristol-Myers Squibb Foundation

Making An Impact: Bristol-Myers Squibb 2018 Global Citizenship Report

Blog

From building partnerships to help ensure patients have access to treatments to ensuring that its commitment to diversity and inclusion extends beyond the workplace, Bristol-Myers Squibb is steadfast in its commitment to being a good corporate citizen. The 2018 Global Citizenship Reports shares stories of the work the company is carrying out as part of its commitment to its people and the communities in which they live.

Bristol-Myers Squibb Foundation Supports Hurricane Florence Relief Efforts in the Southeast U.S.

Press Release

The Bristol-Myers Squibb Foundation is supporting emergency relief effort in the southeastern United States following Hurricane Florence, which made landfall in North Carolina on September 14. The storm is slowly moving across the Carolinas, causing widespread flooding, destroying homes and forcing thousands of residents to flee. 

Bristol-Myers Squibb Named Top 10 Company for Diversity & Inclusion

In the 2018 Thomson Reuters’ Diversity & Inclusion Index
Multimedia with summary

We’re honored to be in the top 10 of Thomson Reuters’ 2018 Diversity & Inclusion (D&am

Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research

More than 100 company employees will ride across the country with the goal of raising $1 million for cancer research
Press Release

PRINCETON, N.J., September 5, 2018 /3BL Media/ -- Today, for the fifth year in a row, Bristol-Myers Squibb Company (NYSE:BMY) is launching 

Global HOPE – Our Journey One Year Later

By John Damonti, President, Bristol-Myers Squibb Foundation
Blog

How do you treat 11,000 new cases of pediatric cancer annually with only five pediatric oncologists?

With those numbers, it’s not surprising the mortality rate for pediatric cancer in Botswana, Malawi and Uganda in southern and east Africa is as high as 90 percent.

Pages

Subscribe to Bristol-Myers Squibb